share_log
Moomoo 24/7 ·  Apr 4 12:34
TC BioPharm Shares Are Trading Higher After the Company Announced the Execution of a Non-binding Letter of Intent as Part of Its M&A Strategy Aimed at Expanding Its Therapeutic Platform and Leveraging NK Cells in Treating Both Solid Tumors and Other Indications
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment